Tower Research Capital (TRC)’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.7K | Buy |
856
+248
| +41% | +$7.85K | ﹤0.01% | 3107 |
|
|
2025
Q4 | $13.3K | Sell |
608
-442
| -42% | -$9.18K | ﹤0.01% | 3418 |
|
|
2025
Q3 | $22.5K | Sell |
1,050
-595
| -36% | -$13.3K | ﹤0.01% | 3205 |
|
|
2025
Q2 | $42.2K | Buy |
1,645
+1,233
| +299% | +$36.1K | ﹤0.01% | 3113 |
|
|
2025
Q1 | $15.1K | Sell |
412
-259
| -39% | -$8.91K | ﹤0.01% | 3243 |
|
|
2024
Q4 | $20.6K | Sell |
671
-7,128
| -91% | -$237K | ﹤0.01% | 3159 |
|
|
2024
Q3 | $294K | Buy |
7,799
+853
| +12% | +$32.9K | 0.01% | 1277 |
|
|
2024
Q2 | $275K | Buy |
6,946
+4,661
| +204% | +$151K | ﹤0.01% | 1832 |
|
|
2024
Q1 | $76.8K | Sell |
2,285
-932
| -29% | -$31.3K | ﹤0.01% | 1987 |
|
|
2023
Q4 | $107K | Sell |
3,217
-8,483
| -73% | -$274K | ﹤0.01% | 2600 |
|
|
2023
Q3 | $367K | Buy |
11,700
+11,098
| +1,844% | +$349K | 0.01% | 1055 |
|
|
2023
Q2 | $19.1K | Buy |
602
+117
| +24% | +$3.78K | ﹤0.01% | 3431 |
|
|
2023
Q1 | $16K | Buy |
485
+88
| +22% | +$2.88K | ﹤0.01% | 3675 |
|
|
2022
Q4 | $13K | Sell |
397
-933
| -70% | -$31.8K | ﹤0.01% | 3574 |
|
|
2022
Q3 | $48K | Sell |
1,330
-1,404
| -51% | -$58.3K | ﹤0.01% | 3181 |
|
|
2022
Q2 | $112K | Buy |
2,734
+2,613
| +2,160% | +$127K | ﹤0.01% | 2192 |
|
|
2022
Q1 | $7K | Sell |
121
-567
| -82% | -$31K | ﹤0.01% | 4687 |
|
|
2021
Q4 | $40K | Buy |
688
+276
| +67% | +$16.8K | ﹤0.01% | 2936 |
|
|
2021
Q3 | $25K | Sell |
412
-1,639
| -80% | -$96.1K | ﹤0.01% | 3510 |
|
|
2021
Q2 | $123K | Buy |
2,051
+1,087
| +113% | +$54.5K | ﹤0.01% | 2257 |
|
|
2021
Q1 | $46K | Sell |
964
-538
| -36% | -$22.1K | ﹤0.01% | 3188 |
|
|
2020
Q4 | $56K | Sell |
1,502
-12,638
| -89% | -$416K | ﹤0.01% | 2989 |
|
|
2020
Q3 | $462K | Buy |
14,140
+12,455
| +739% | +$527K | 0.01% | 1767 |
|
|
2020
Q2 | $76K | Buy |
+1,685
| New | +$86.1K | ﹤0.01% | 2697 |
|
|
2019
Q4 | – | Sell |
-1,935
| Closed | -$70K | – | 3512 |
|
|
2019
Q3 | $70K | Buy |
+1,935
| New | +$81.6K | ﹤0.01% | 1557 |
|
|
2019
Q1 | – | Sell |
-572
| Closed | -$21K | – | 3769 |
|
|
2018
Q4 | $21K | Buy |
572
+517
| +940% | +$20.2K | ﹤0.01% | 1892 |
|
|
2018
Q3 | $2K | Sell |
55
-263
| -83% | -$7.69K | ﹤0.01% | 3403 |
|
|
2018
Q2 | $8K | Buy |
+318
| New | +$8.86K | ﹤0.01% | 2867 |
|
|
2018
Q1 | – | Sell |
-1,825
| Closed | -$59K | – | 3234 |
|
|
2017
Q4 | $59K | Buy |
1,825
+1,669
| +1,070% | +$53.7K | 0.01% | 1200 |
|
|
2017
Q3 | $5K | Buy |
+156
| New | +$4.27K | ﹤0.01% | 3290 |
|
|
2017
Q2 | – | Sell |
-99
| Closed | -$2K | – | 2681 |
|
|
2017
Q1 | $2K | Sell |
99
-191
| -66% | -$4.32K | ﹤0.01% | 2586 |
|
|
2016
Q4 | $7K | Sell |
290
-17
| -6% | -$410 | ﹤0.01% | 2830 |
|
|
2016
Q3 | $7K | Buy |
307
+296
| +2,691% | +$6.61K | ﹤0.01% | 2303 |
|
|
2016
Q2 | $0 | Sell |
11
-89
| -89% | -$2.8K | ﹤0.01% | 4408 |
|
|
2016
Q1 | $3K | Buy |
100
+57
| +133% | +$1.51K | ﹤0.01% | 3043 |
|
|
2015
Q4 | $1K | Sell |
43
-528
| -92% | -$14.4K | ﹤0.01% | 4014 |
|
|
2015
Q3 | $17K | Sell |
571
-2,197
| -79% | -$71.9K | ﹤0.01% | 1864 |
|
|
2015
Q2 | $116K | Buy |
+2,768
| New | +$131K | 0.01% | 682 |
|
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
Tower Research Capital (TRC)'s ATEX Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Anterix (ATEX) stake by 41% in Q1 2026, buying an estimated $7.85K and bringing the position to 856 shares worth $32.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3107.
Tower Research Capital (TRC) first reported a position in ATEX in Q2 2015 and has held it in 38 quarters since. The position peaked at $462K in Q3 2020. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- Tower Research Capital (TRC) held 856 shares of Anterix worth $32.7K as of Q1 2026.
- Tower Research Capital (TRC) bought 248 Anterix shares in Q1 2026, an estimated $7.85K.
- Anterix made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3107 holding.
- Tower Research Capital (TRC) first reported a position in Anterix in Q2 2015 and has held it in 38 quarters since.
- Tower Research Capital (TRC)'s Anterix position peaked at $462K in Q3 2020.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.